×

Oxidoreductase activity of manganic porphyrins

  • US 6,103,714 A
  • Filed: 07/24/1996
  • Issued: 08/15/2000
  • Est. Priority Date: 09/20/1994
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of effecting oxidoreduction in a patient comprising administering to said patient a metallic porphyrin complex having substituents on the methine carbons of the porphyrin, in an effective, nontoxic amount, so that said complex is reduced by a reductant present in said patient and reoxidized by O2- present in said patient.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×